Document Classification

Section Type: RESULTS

Text: Comparing data at the end of placebo and captopril treatment, captopril resulted in : lower blood pressure (systolic 154 + / - 2 vs. 163 + / - 3 mmHg and diastolic 93 + / - 2 vs. 101 + / - 2 mmHg) ; greater insulin sensitivity in hyperglycemic conditions (total amount of insulin infused and time of insulin infusion required to reach euglycemia, 1. 73 + / - 0. 54 vs. 2. 08 + / - 0. 60 U and 58 + / - 8 vs. 70 + / - 11 min, captopril and placebo, respectively, P < 0. 05) ; greater insulin sensitivity in euglycemic conditions at liver level (hepatic glucose output 4. 11 + / - 0. 55 vs. 5. 2 + / - 0. 4 mumol. kg-1.